Status:
UNKNOWN
Incidence of TNS After Intrathecal Lidocaine v.s Bupivacaine
Lead Sponsor:
McGill University Health Centre/Research Institute of the McGill University Health Centre
Conditions:
Orthopedic Disorder
Leg Injuries
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
This study will look into the incidence of Transient neurological symptoms (TNS) after the intrathecal use of lidocaine in comparison to intrathecal Bupivacaine.
Detailed Description
Ever since the introduction of Spinal anesthesia in 1898 by the German surgeon August Bier, the approach gained wide acceptance by the anesthesia community 1. Since that time, the technique has evolve...
Eligibility Criteria
Inclusion
- ASA I-III male and female patients aged between 18 to 80 years old, who will receive spinal anesthesia for surgeries lasting less than one hour.
Exclusion
- Patients younger than 18 years old.
- ASA physical status \>3.
- Immunosuppression or high risk of infection.
- Contraindications to receiving spinal anesthesia (e.g. coagulation impairment).
- Patients with psychosis
- Patients with preexisting back pain.
- Patients with cognitive impairment
- Allergies to local anesthetics, analgesics or any medication used in the study.
- Patients with chronic regular opioid usage
- Presence of preexisting neurological symptoms.
Key Trial Info
Start Date :
November 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2019
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT03862287
Start Date
November 1 2018
End Date
December 1 2019
Last Update
March 5 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Montreal General Hospital
Montreal, Quebec, Canada, H3A 1A1